Trial intelligence / Profile preview

Effectiveness Of Different Fibrinogen Preparations In Restoring Clot Firmness

2022-001105-40Phase 2Completed

Sponsor
Policlinico San Donato
Start
Oct 2022
Modality
Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised trial in postoperative hemorrhage and cardiac disease comparing RIASTAP with FIBRICLOTTE (2 arms). Primary endpoint: Clot firmness and clot formation parameters. Started Oct 2022; status: completed.

02

Drugs

Fibrinogen humanhuman fibrinogen albumin microspheres
03

Conditions

postoperative hemorrhagecardiac disease

Beyond the preview

Go deeper on 2022-001105-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2022-001105-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call